Connect with us

Life Sciences

HealthTrust Performance Group Selects Everstream Analytics To Enhance Resilience and Continuity in the Global Healthcare Value Chain

HealthTrust Enhances AI-Powered Supply Chain Intelligence to Benefit Providers and Members Everstream Analytics, the global supply chain insights and…

Published

on

This article was originally published by AITHORITY
HealthTrust Performance Group Selects Everstream Analytics To Enhance Resilience and Continuity in the Global Healthcare Value Chain

HealthTrust Enhances AI-Powered Supply Chain Intelligence to Benefit Providers and Members

Everstream Analytics, the global supply chain insights and risk analytics company, announced that HealthTrust Performance Group (HealthTrust), a leading healthcare performance improvement company, has selected Everstream as its global supply chain risk management provider.

AiThority Interview Insights: AiThority Interview with Patrick Murphy, Chief Executive Officer of Togal.AI

“Supply chain risk management is critical to the continuity of the healthcare value chain and has always been a priority for HealthTrust”

Through total spend management solutions, including group purchasing and operator-led expertise in supply chain resilience, clinical integration and workforce, HealthTrust strengthens provider performance and clinical excellence. HealthTrust will leverage the Everstream platform to proactively identify and manage risk, and to strengthen long-term supply chain resilience.

“Supply chain risk management is critical to the continuity of the healthcare value chain and has always been a priority for HealthTrust,” said Jocelyn Bradshaw, HealthTrust Senior Vice President, Strategic Sourcing. “By teaming with Everstream, we are gaining additional insights that will continue to strengthen our sourcing organization and ultimately the entire healthcare supply ecosystem.”

Read More about AiThority InterviewAiThority Interview with Raj Suri, Founder at Presto Automation

Assessing the potential impact of supply chain disruption in healthcare is complex. Through this strategic relationship, HealthTrust will receive enhanced visibility, transparency and understanding of the healthcare supply chain. With Everstream, HealthTrust can access dynamic supply chain and material mapping, from Tier-1 manufacturing sites to sub-tier visibility. Intelligent data will improve event response thanks to faster insights and more context regarding how disruption can impact products, materials and healthcare providers.

“We are thrilled to work with HealthTrust and its members to improve healthcare resilience and continuity,” said Julie Gerdeman, Everstream CEO. “The global healthcare value chain sustains human life, making it one of the most crucial networks on the planet. It’s also one of the most complex, under constant scrutiny from regulators and consumers. Our AI-powered supply chain risk intelligence will help HealthTrust manage – and prevent – some of the many daily challenges this industry faces so it can continue delivering on its mission to protect human health and patient safety.

 Latest AiThority Interview Insights : AiThority Interview with Manuvir Das, VP, Enterprise Computing at NVIDIA

 [To share your insights with us, please write to sghosh@martechseries.com] 

The post HealthTrust Performance Group Selects Everstream Analytics To Enhance Resilience and Continuity in the Global Healthcare Value Chain appeared first on AiThority.



Life Sciences

Wittiest stocks:: Avalo Therapeutics Inc (NASDAQ:AVTX 0.00%), Nokia Corp ADR (NYSE:NOK 0.90%)

There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well…

Continue Reading
Life Sciences

Spellbinding stocks: LumiraDx Limited (NASDAQ:LMDX 4.62%), Transocean Ltd (NYSE:RIG -2.67%)

There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well…

Continue Reading
Life Sciences

Asian Fund for Cancer Research announces Degron Therapeutics as the 2023 BRACE Award Venture Competition Winner

The Asian Fund for Cancer Research (AFCR) is pleased to announce that Degron Therapeutics was selected as the winner of the 2023 BRACE Award Venture Competition….

Continue Reading

Trending